Published in J Clin Invest on February 01, 1986
Incidence and pathophysiology of hypercalcemia. Calcif Tissue Int (1990) 0.79
Production of parathyroid hormone-related protein in tumour xenografts in nude mice presenting with hypercalcaemia. Br J Cancer (1991) 0.76
Resolution of hypercalcemia of malignancy following radical cystectomy in a patient with paraneoplastic syndrome associated with urothelial carcinoma of the bladder. Urol Ann (2015) 0.75
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A (1978) 8.01
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A (1980) 6.32
Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A (1980) 3.45
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med (1980) 3.15
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Hypercalcaemia--a hospital survey. Q J Med (1980) 2.50
Bone-resorbing activity in supernatants from lymphoid cell lines. N Engl J Med (1974) 2.08
The hypercalcemia of malignancy: pathogenesis and management. Metabolism (1982) 2.01
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. J Clin Invest (1983) 1.84
Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. N Engl J Med (1970) 1.83
Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest (1983) 1.77
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1983) 1.75
Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab (1982) 1.68
Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Science (1983) 1.52
Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy. Am J Med (1978) 1.47
Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria. Biochem Biophys Res Commun (1978) 1.41
Direct resorption of bone by human breast cancer cells in vitro. Nature (1978) 1.33
Monocytes regulate osteoclast-activating factor production by releasing prostaglandins. J Exp Med (1979) 1.32
Hypercalcemia in neoplastic disease. Arch Surg (1960) 1.31
Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. J Clin Invest (1974) 1.30
Endogenous biologically active human parathyroid hormone: measurement by a guanyl nucleotide-amplified renal adenylate cyclase assay. J Clin Endocrinol Metab (1981) 1.12
A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy. Cancer (1982) 1.11
EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy. Endocrinology (1985) 1.11
Urinary and nephrogenous adenosine 3',5'-monophosphate in the hypercalcemia of malignancy. J Clin Endocrinol Metab (1981) 1.06
Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma. Br J Haematol (1981) 1.04
Prostaglandins as mediators of bone resorption in renal and breast tumours. Clin Sci (Lond) (1980) 0.99
Metabolism of parathyroid hormone by Kupffer cells: analysis by reverse-phase high-performance liquid chromatography. Biochemistry (1982) 0.96
Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors. J Clin Endocrinol Metab (1981) 0.95
Calcium metabolism in cancer. Studies using calcium isotopes and immunoassays for parathyroid hormone and calcitonin. Cancer (1976) 0.95
Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer. J Clin Endocrinol Metab (1980) 0.92
Stimulation of prostaglandin production in bone by phorbol diesters and melittin. Prostaglandins (1978) 0.88
The effect of dexamethasone on parathyroid hormone stimulation of adenylate cyclase in ROS 17/2.8 cells. Endocrinology (1984) 0.87
Cyclo-oxygenase products of arachidonic acid metabolism in rat osteoblasts in culture. Calcif Tissue Int (1983) 0.83
Nephrogenous cyclic AMP. Recent Prog Horm Res (1981) 0.81
An assay for osteoclast-activating factor (OAF) in biological fluids: detection of OAF in the serum of myeloma patients. Cell Immunol (1980) 0.79
Presence of prostaglandin E in lung tumors from normocalcemic patients. Am J Med (1982) 0.77
Osteoblastic cells regulate the haematopoietic stem cell niche. Nature (2003) 19.60
Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science (1996) 8.14
PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33
Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science (1992) 5.00
Yeast Bim1p promotes the G1-specific dynamics of microtubules. J Cell Biol (1999) 3.20
Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol (2001) 3.13
Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A (1992) 2.98
Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25. J Biol Chem (1992) 2.76
EB1 proteins regulate microtubule dynamics, cell polarity, and chromosome stability. J Cell Biol (2000) 2.76
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem (1987) 2.38
Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology (1995) 2.25
CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature (1995) 2.15
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem (1985) 2.14
Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood (1989) 2.13
The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules. Proc Natl Acad Sci U S A (1998) 2.05
Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci U S A (1995) 2.03
Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia. Clin Chem (1992) 1.86
Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology (1996) 1.86
The APC-associated protein EB1 associates with components of the dynactin complex and cytoplasmic dynein intermediate chain. Curr Biol (1999) 1.85
Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc Natl Acad Sci U S A (1992) 1.82
Immunophilins in protein folding and immunosuppression. FASEB J (1994) 1.80
Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med (1982) 1.71
Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science (1992) 1.68
The spectrum of bone disease in end-stage renal failure--an evolving disorder. Kidney Int (1993) 1.68
Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. J Exp Med (1987) 1.61
CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature (1991) 1.60
Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13. Proc Natl Acad Sci U S A (1991) 1.58
Optimal antibiotic therapy in cholera. Bull World Health Organ (1968) 1.58
A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis. N Engl J Med (1980) 1.54
Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab (1988) 1.46
Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol (2000) 1.46
Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood (1992) 1.43
Probable gallbladder infection in convalescent cholera patients. Lancet (1967) 1.39
Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells. Endocrinology (1993) 1.37
The amino-acid sequence of the amino-terminal 37 residues of human parathyroid hormone. Proc Natl Acad Sci U S A (1974) 1.37
Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology (1993) 1.36
Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells. Mol Cell Biol (1985) 1.34
CD28/CTLA-4 and CD80/CD86 families: signaling and function. Immunol Res (1999) 1.32
Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology (1993) 1.31
Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J Biol Chem (2001) 1.30
Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer (1998) 1.28
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int (1994) 1.28
Metabolism of parathyroid hormone: physiologic and clinical significance. Am J Med (1974) 1.25
Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology (1994) 1.25
Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Bone (2007) 1.24
Steroid-induced meiotic division in Xenopus laevis oocytes: surface and calcium. Nature (1978) 1.24
Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol (1996) 1.23
Actin stabilization by jasplakinolide enhances apoptosis induced by cytokine deprivation. J Biol Chem (1999) 1.22
The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology (1998) 1.22
Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int (1994) 1.21
Functional analysis of the PTH/PTHrP network of ligands and receptors. Recent Prog Horm Res (1998) 1.19
Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation. Proc Natl Acad Sci U S A (1995) 1.19
Conditionally immortalized murine bone marrow stromal cells mediate parathyroid hormone-dependent osteoclastogenesis in vitro. Endocrinology (1998) 1.19
Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (1989) 1.18
Immunoreactive parathyroid hormone in circulation of man. Nat New Biol (1972) 1.17
Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. J Immunol (1992) 1.16
Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). J Biol Chem (1996) 1.14
The parathyroid hormone-like peptide associated with humoral hypercalcemia of malignancy and parathyroid hormone bind to the same receptor on the plasma membrane of ROS 17/2.8 cells. J Biol Chem (1988) 1.14
The chemistry of growth hormone and the lactogenic hormones. Recent Prog Horm Res (1973) 1.13
Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome. Nature (1991) 1.13
C-myc expression is dissociated from DNA synthesis and cell division in Xenopus oocyte and early embryonic development. EMBO J (1986) 1.13
Formation of a synovial-like membrane at the bone-cement interface. Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum (1986) 1.12
The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). Endocrinology (1994) 1.12
Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc Natl Acad Sci U S A (1992) 1.11
Characterization of parathyroid hormone receptors in canine renal cortical plasma membranes using a radioiodinated sulfur-free hormone analogue. Correlation of binding with adenylate cyclase activity. J Biol Chem (1979) 1.11
Localization of the FK506-binding protein, FKBP 13, to the lumen of the endoplasmic reticulum. Biochem J (1993) 1.11
The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med (1984) 1.10
Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis (1995) 1.09
Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding. Endocrinology (1994) 1.08
Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int (1993) 1.08
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia. Bone Marrow Transplant (1997) 1.08
Tumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content. EMBO J (1984) 1.07
Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Eur J Immunol (1991) 1.07
Hypercalcemia in pheochromocytoma. Evidence for a novel mechanism. Ann Intern Med (1985) 1.07
In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats. Bone (1993) 1.06
Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology (2001) 1.06
Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion. Bone (2003) 1.05
Parathyroid hormone-related protein and Indian hedgehog control the pace of cartilage differentiation. J Endocrinol (1997) 1.04
Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int (1998) 1.04
Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas. Eur J Immunol (1992) 1.04
Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands. Biochemistry (1999) 1.04
A distinct cytoplasmic domain of CD2 regulates ligand avidity and T-cell responsiveness to antigen. Proc Natl Acad Sci U S A (1992) 1.03
Dual signaling and ligand selectivity of the human PTH/PTHrP receptor. J Bone Miner Res (1999) 1.01
T3 glycoprotein is functional although structurally distinct on human T-cell receptor gamma T lymphocytes. Proc Natl Acad Sci U S A (1987) 1.01
G alpha q family members couple parathyroid hormone (PTH)/PTH-related peptide and calcitonin receptors to phospholipase C in COS-7 cells. Mol Endocrinol (1996) 1.01
Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood (1994) 1.00
The rat, mouse and human genes encoding the receptor for parathyroid hormone and parathyroid hormone-related peptide are highly homologous. Biochem Biophys Res Commun (1994) 1.00
Lamins A and C are not expressed at early stages of human lymphocyte differentiation. Exp Cell Res (1990) 0.99
Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes. J Immunol (1991) 0.98
Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation. Eur J Immunol (1994) 0.98
Signaling via LAT (linker for T-cell activation) and Syk/ZAP70 is required for ERK activation and NFAT transcriptional activation following CD2 stimulation. Blood (2000) 0.98
Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology (2002) 0.98
Development and application of sequence-specific radioimmunoassays for analysis of the metabolism of parathyroid hormone. Methods Enzymol (1975) 0.98
Metabolism of parathyroid hormone by Kupffer cells: analysis by reverse-phase high-performance liquid chromatography. Biochemistry (1982) 0.96
Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins. Proc Natl Acad Sci U S A (1994) 0.96